Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BY-NC 4.0Human Vaccines & Immunotherapeutics

Activation of IgG antibody and mucosal T cell responses to MERS-CoV in human nasopharynx-associated lymphoid tissue by a ChAdOx1 vectored vaccine candidate and inactivated MERS-CoV

6 affiliations
  1. 1Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK
  2. 2Department of Medical Virology, Vector-Borne Diseases Laboratories, Public Health Authority, Jazan, Saudi Arabia
  3. 3ENT Departments, Alder Hey Children’s Hospital, Liverpool, UK
  4. 4ENT Departments, Aintree University Hospital, Liverpool, UK
  5. 5Jenner Vaccine Institute; Oxford Vaccine Group; Pandemic Sciences Institute; CAMS Oxford Institute, University of Oxford ; Chinese Academy of Medical Sciences & Peking Union Medical College, Oxford, UK
  6. 6Section of Immunology, Department of Microbes, Infection and Immunity, University of Surrey, Surrey, UK

Abstract

Middle East respiratory syndrome coronavirus (MERS-CoV) causes serious infection in humans with up to 40% mortality. As MERS-CoV infects humans via nasopharyngeal mucosa, local mucosal immunization may provide an effective vaccination strategy. Nasopharynx-associated lymphoid tissues (NALT, comprising adenotonsillar tissues) are immune induction sites for intranasal vaccines. We studied the capacity of a viral vectored MERS candidate vaccine (ChAdOx1 MERS) and inactivated MERS-CoV in activating cellular and antibody responses in the NALT. Mononuclear cells isolated from adenotonsillar tissues from children and adults were stimulated with ChAdOx1 MERS and heat- or radiation-inactivated MERS-CoV, followed by analysis of anti-MERS IgG antibody and cytokines (IFNγ and TNFα) in cell culture supernatants by ELISA. CD4+ and CD8+ T cell responses, including proliferation and expression of cytokines and cytotoxic molecules were evaluated by flow cytometry. ChAdOx1 MERS induced marked spike-specific anti-MERS IgG antibody responses, which were significantly stronger than those induced by inactivated MERS-CoV. ChAdOx1 MERS also activated higher CD4+ and CD8+ T cell proliferative responses, cytokine expression (IFNγ, TNFα) by CD4+ T cells and cytotoxic perforin and granzyme B expression by CD8+ T cells than by inactivated MERS-CoV. Both antibody and T cell responses were shown stronger in adults than in children. There was a positive correlation between CD4+ T cell proliferation and the antibody response. Human NALT offers an efficient immune induction site for Spike-specific anti-MERS antibody and T cell response. Viral vectored ChAdOx1 MERS induces marked antibody and T cell responses in the NALT, supporting its potential as a mucosal (e.g. intranasal) vaccine against MERS.

Related

  1. AMnESTI Reverses Age-Associated Lung Immune Decline to Drive Heterosubtypic Protection by Inactivated Influenza Vaccines
    Shilin Gao, Quanwei Zhang, Asmita Banstola +4
    Science immunologyPeer-reviewedLicence not statedFull textEpidemiology & public healthPMC
  2. Ex vivo IL-1β, IL-6, TNF-α, and IL-8 responses 2 years after critical COVID-19 are associated with age and innate immune activation
    Luka Hiti, Maša Kandušer, Tilen Burnik +7
    Scientific ReportsPeer-reviewedCC BY 4.0Full textInfectious diseaseCrossref
  3. Study on the clinical outcomes of COVID-19 infection and immune responses following the third booster dose of inactivated COVID-19 vaccine in hematologic disease patients
    Haiying Zhang, Xin Wang, Runling Zhang +4
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textInfectious diseaseCrossrefEurope PMCPMC
  4. A Unique Case of Odontoid Metastasis Reveals Nasopharynx Carcinoma: Case Management With the Posterolateral Epidural Supra-C2-Root Approach (PESCA) Technique in Open Surgery
    Mehfoud Ibrahim, Mohamed Khoulali, Mohamed Dahamou +2
    CureusPeer-reviewedCC BYFull textMedical imaging & radiologyEurope PMCPMC
  5. Presence of Dolosigranulum pigrum in the nasopharynx and its relationship with respiratory health status in paediatric population
    Maria Cisneros, Desirée Henares, Aleix Lluansí +9
    PLOS OnePeer-reviewedCC BY 4.0Full textMicrobiologyStatisticsPLOS
BibTeX
@article{shrwani2026activation,
  title = {{Activation of IgG antibody and mucosal T cell responses to MERS-CoV in human nasopharynx-associated lymphoid tissue by a ChAdOx1 vectored vaccine candidate and inactivated MERS-CoV}},
  author = {Khalid J. Shrwani and Ravi Sharma and Madhankumar Krishnan and Samuel Leong and Teresa Lambe and Sarah C. Gilbert and Nigel Cunliffe and Qibo Zhang},
  journal = {Human Vaccines \& Immunotherapeutics},
  year = {2026},
  month = nov,
  doi = {10.1080/21645515.2026.2756059},
  url = {https://doi.org/10.1080/21645515.2026.2756059},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Activation of IgG antibody and mucosal T cell responses to MERS-CoV in human nasopharynx-associated lymphoid tissue by a ChAdOx1 vectored vaccine candidate and inactivated MERS-CoV
AU  - Khalid J. Shrwani
AU  - Ravi Sharma
AU  - Madhankumar Krishnan
AU  - Samuel Leong
AU  - Teresa Lambe
AU  - Sarah C. Gilbert
AU  - Nigel Cunliffe
AU  - Qibo Zhang
PY  - 2026
DA  - 2026/11/09
JO  - Human Vaccines & Immunotherapeutics
DO  - 10.1080/21645515.2026.2756059
UR  - https://doi.org/10.1080/21645515.2026.2756059
AB  - Middle East respiratory syndrome coronavirus (MERS-CoV) causes serious infection in humans with up to 40% mortality. As MERS-CoV infects humans via nasopharyngeal mucosa, local mucosal immunization may provide an effective vaccination strategy. Nasopharynx-associated lymphoid tissues (NALT, comprising adenotonsillar tissues) are immune induction sites for intranasal vaccines. We studied the capacity of a viral vectored MERS candidate vaccine (ChAdOx1 MERS) and inactivated MERS-CoV in activating cellular and antibody responses in the NALT. Mononuclear cells isolated from adenotonsillar tissues from children and adults were stimulated with ChAdOx1 MERS and heat- or radiation-inactivated MERS-CoV, followed by analysis of anti-MERS IgG antibody and cytokines (IFNγ and TNFα) in cell culture supernatants by ELISA. CD4+ and CD8+ T cell responses, including proliferation and expression of cytokines and cytotoxic molecules were evaluated by flow cytometry. ChAdOx1 MERS induced marked spike-specific anti-MERS IgG antibody responses, which were significantly stronger than those induced by inactivated MERS-CoV. ChAdOx1 MERS also activated higher CD4+ and CD8+ T cell proliferative responses, cytokine expression (IFNγ, TNFα) by CD4+ T cells and cytotoxic perforin and granzyme B expression by CD8+ T cells than by inactivated MERS-CoV. Both antibody and T cell responses were shown stronger in adults than in children. There was a positive correlation between CD4+ T cell proliferation and the antibody response. Human NALT offers an efficient immune induction site for Spike-specific anti-MERS antibody and T cell response. Viral vectored ChAdOx1 MERS induces marked antibody and T cell responses in the NALT, supporting its potential as a mucosal (e.g. intranasal) vaccine against MERS.
SN  - 2164-5515
SN  - 2164-554X
ER  -